ClassID:

111550

C12N2770/32434 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Picornaviridae; Hepatovirus, i.e. hepatitis A virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20220089649
2022-03-24

Method for extracting hepatitis a virus (HAV) antigen from cell culture

#2
20210008196
2021-01-14

Duck hepatitis A virus type 3 mutant CH-P60-117C and construction thereof

#3
20200405838
2020-12-31

compositions and methods thereof

#4
20200164056
2020-05-28

compositions and methods thereof

#5
20160228540
2016-08-11

Nasal mucosal vaccine composition

#6
20160193327
2016-07-07

Mucosal vaccine composition

#7
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

#8
20150329598
2015-11-19

Stabilized hepatitis B core polypeptides

#9
20140339126
2014-11-20

Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

#10
20140105992
2014-04-17

Vaccine

#11
20140099335
2014-04-10

DNA vaccine

#12
20140004150
2014-01-02

Vaccine injection, preparation method and use thereof

#13
20120156240
2012-06-21

Methods for preparing vesicles and formulations produced therefrom

#14
20110311573
2011-12-22

Method for preparing recombinant antigen complex using rotavirus nanoparticle

#15
20110177163
2011-07-21

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A

#16
20100310656
2010-12-09

Immunotherapy and prevention of autoimmune hepatitis

#17
20080226672
2008-09-18

Adjuvant systems and vaccines

#18
20070031450
2007-02-08

Stabilizers for veterinary vaccines

#19
20060171956
2006-08-03

Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination

#20
20050118275
2005-06-02

Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

#21
20050112144
2005-05-26

Hepatitis A vaccines